# American Superconductor Corp: financial statements, quarterly

AMSC · Nasdaq · CIK 880807 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/amsc.md) · [Financials](/companies/amsc/financials.md) · [Filings](/companies/amsc/filings.md) · [Insiders](/companies/amsc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amsc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | Q4 FY2023 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q3 FY2024 (2024-12-31) | Q4 FY2024 (2025-03-31) | Q1 FY2025 (2025-06-30) | Q2 FY2025 (2025-09-30) | Q3 FY2025 (2025-12-31) | Q4 FY2025 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [34.0](/filings/0001437749-24-032618.md) | [39.4](/filings/0001437749-25-002900.md) | [42.0 d](/filings/0001437749-26-018542.md) | [40.3](/filings/0001437749-25-023968.md) | [54.5](/filings/0001437749-25-033351.md) | [61.4](/filings/0001437749-26-002978.md) | [66.7 d](/filings/0001437749-26-018542.md) | [72.4](/filings/0001437749-26-025922.md) | [65.9](/filings/0001437749-25-033351.md) | [74.5](/filings/0001437749-26-002978.md) | [86.4 d](/filings/0001437749-26-018542.md) | [94.1](/filings/0001437749-26-025922.md) |
| Cost of revenue | $m | [25.4](/filings/0001437749-24-032618.md) | [29.4](/filings/0001437749-25-002900.md) | [31.6 d](/filings/0001437749-26-018542.md) | [28.1](/filings/0001437749-25-023968.md) | [38.9](/filings/0001437749-25-033351.md) | [45.1](/filings/0001437749-26-002978.md) | [49.0 d](/filings/0001437749-26-018542.md) | [47.9](/filings/0001437749-26-025922.md) | [45.4](/filings/0001437749-25-033351.md) | [51.7](/filings/0001437749-26-002978.md) | [62.8 d](/filings/0001437749-26-018542.md) | [69.3](/filings/0001437749-26-025922.md) |
| Gross profit | $m | [8.6](/filings/0001437749-24-032618.md) | [10.0](/filings/0001437749-25-002900.md) | [10.4 d](/filings/0001437749-26-018542.md) | [12.2](/filings/0001437749-25-023968.md) | [15.6](/filings/0001437749-25-033351.md) | [16.3](/filings/0001437749-26-002978.md) | [17.7 d](/filings/0001437749-26-018542.md) | [24.5](/filings/0001437749-26-025922.md) | [20.4](/filings/0001437749-25-033351.md) | [22.9](/filings/0001437749-26-002978.md) | [23.6 d](/filings/0001437749-26-018542.md) | [24.7](/filings/0001437749-26-025922.md) |
| Research and development | $m | [1.6](/filings/0001437749-24-032618.md) | [2.2](/filings/0001437749-25-002900.md) | [2.3 d](/filings/0001437749-26-018542.md) | [2.3](/filings/0001437749-25-023968.md) | [2.6](/filings/0001437749-25-033351.md) | [3.0](/filings/0001437749-26-002978.md) | [3.5 d](/filings/0001437749-26-018542.md) | [4.3](/filings/0001437749-26-025922.md) | [3.7](/filings/0001437749-25-033351.md) | [3.5](/filings/0001437749-26-002978.md) | [4.2 d](/filings/0001437749-26-018542.md) | [3.9](/filings/0001437749-26-025922.md) |
| Selling, general and administrative | $m | [7.9](/filings/0001437749-24-032618.md) | [7.8](/filings/0001437749-25-002900.md) | [8.0 d](/filings/0001437749-26-018542.md) | [8.9](/filings/0001437749-25-023968.md) | [10.5](/filings/0001437749-25-033351.md) | [11.6](/filings/0001437749-26-002978.md) | [12.1 d](/filings/0001437749-26-018542.md) | [14.2](/filings/0001437749-26-025922.md) | [13.4](/filings/0001437749-25-033351.md) | [15.4](/filings/0001437749-26-002978.md) | [14.6 d](/filings/0001437749-26-018542.md) | [18.6](/filings/0001437749-26-025922.md) |
| Operating income | $m | [(2.4)](/filings/0001437749-24-032618.md) | [(1.4)](/filings/0001437749-25-002900.md) | [(2.2) d](/filings/0001437749-26-018542.md) | [(3.3)](/filings/0001437749-25-023968.md) | [(0.8)](/filings/0001437749-25-033351.md) | [1.3](/filings/0001437749-26-002978.md) | [1.7 d](/filings/0001437749-26-018542.md) | [5.6](/filings/0001437749-26-025922.md) | [3.0](/filings/0001437749-25-033351.md) | [3.4](/filings/0001437749-26-002978.md) | [(0.5) d](/filings/0001437749-26-018542.md) | [9.8](/filings/0001437749-26-025922.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001437749-24-032618.md) | [0.1](/filings/0001437749-25-002900.md) | [0.0 d](/filings/0001437749-26-018542.md) | [0.2](/filings/0001437749-25-023968.md) | [(5.0)](/filings/0001437749-25-033351.md) | [(0.1)](/filings/0001437749-26-002978.md) | [1.2 d](/filings/0001437749-26-018542.md) | [0.2](/filings/0001437749-26-025922.md) | [0.1](/filings/0001437749-25-033351.md) | [(112)](/filings/0001437749-26-002978.md) | [(5.0) d](/filings/0001437749-26-018542.md) | [1.3](/filings/0001437749-26-025922.md) |
| Net income | $m | [(2.5)](/filings/0001437749-25-002900.md) | [(1.6)](/filings/0001437749-25-002900.md) | [(11.1)](/filings/0001437749-24-018602.md) | [(2.5)](/filings/0001437749-26-002978.md) | [4.9](/filings/0001437749-26-002978.md) | [2.5](/filings/0001437749-26-002978.md) | [1.2 d](/filings/0001437749-26-018542.md) | [6.7](/filings/0001437749-26-025922.md) | [4.8](/filings/0001437749-26-002978.md) | [118](/filings/0001437749-26-002978.md) | [4.5 d](/filings/0001437749-26-018542.md) | [9.5](/filings/0001437749-26-025922.md) |
| Diluted EPS | $ per share | [(0.09)](/filings/0001437749-24-032618.md) | [(0.06)](/filings/0001437749-25-002900.md) | [(0.37)](/filings/0001437749-24-018602.md) | [(0.07)](/filings/0001437749-25-023968.md) | [0.13](/filings/0001437749-25-033351.md) | [0.06](/filings/0001437749-26-002978.md) | not reported | [0.17](/filings/0001437749-26-025922.md) | [0.11](/filings/0001437749-25-033351.md) | [2.62](/filings/0001437749-26-002978.md) | not reported | [0.20](/filings/0001437749-26-025922.md) |
| Basic EPS | $ per share | [(0.09)](/filings/0001437749-24-032618.md) | [(0.06)](/filings/0001437749-25-002900.md) | [(0.37)](/filings/0001437749-24-018602.md) | [(0.07)](/filings/0001437749-25-023968.md) | [0.13](/filings/0001437749-25-033351.md) | [0.07](/filings/0001437749-26-002978.md) | not reported | [0.17](/filings/0001437749-26-025922.md) | [0.11](/filings/0001437749-25-033351.md) | [2.68](/filings/0001437749-26-002978.md) | not reported | [0.21](/filings/0001437749-26-025922.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | FY2023 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q3 FY2024 (2024-12-31) | FY2024 (2025-03-31) | Q1 FY2025 (2025-06-30) | Q2 FY2025 (2025-09-30) | Q3 FY2025 (2025-12-31) | FY2025 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [22.8](/filings/0001437749-23-029753.md) | [24.0](/filings/0001437749-24-002041.md) | [90.5](/filings/0001437749-25-017986.md) | [93.5](/filings/0001437749-24-024886.md) | [72.1](/filings/0001437749-24-032618.md) | [75.2](/filings/0001437749-25-002900.md) | [79.5](/filings/0001437749-26-018542.md) | [208](/filings/0001437749-25-023968.md) | [213](/filings/0001437749-25-033351.md) | [141](/filings/0001437749-26-002978.md) | [141](/filings/0001437749-26-025922.md) | [144](/filings/0001437749-26-025922.md) |
| Current assets | $m | [104](/filings/0001437749-23-029753.md) | [100](/filings/0001437749-24-002041.md) | [166](/filings/0001437749-25-017986.md) | [173](/filings/0001437749-24-024886.md) | [195](/filings/0001437749-24-032618.md) | [205](/filings/0001437749-25-002900.md) | [207](/filings/0001437749-26-018542.md) | [349](/filings/0001437749-25-023968.md) | [343](/filings/0001437749-25-033351.md) | [325](/filings/0001437749-26-002978.md) | [332](/filings/0001437749-26-025922.md) | [343](/filings/0001437749-26-025922.md) |
| Total assets | $m | [171](/filings/0001437749-23-029753.md) | [166](/filings/0001437749-24-002041.md) | [233](/filings/0001437749-25-017986.md) | [240](/filings/0001437749-24-024886.md) | [298](/filings/0001437749-24-032618.md) | [310](/filings/0001437749-25-002900.md) | [311](/filings/0001437749-26-018542.md) | [453](/filings/0001437749-25-023968.md) | [446](/filings/0001437749-25-033351.md) | [720](/filings/0001437749-26-002978.md) | [739](/filings/0001437749-26-025922.md) | [762](/filings/0001437749-26-025922.md) |
| Current liabilities | $m | [85.3](/filings/0001437749-23-029753.md) | [77.6](/filings/0001437749-24-002041.md) | [78.8](/filings/0001437749-25-017986.md) | [86.2](/filings/0001437749-24-024886.md) | [95.1](/filings/0001437749-24-032618.md) | [104](/filings/0001437749-25-002900.md) | [99.8](/filings/0001437749-26-018542.md) | [105](/filings/0001437749-25-023968.md) | [87.8](/filings/0001437749-25-033351.md) | [122](/filings/0001437749-26-002978.md) | [139](/filings/0001437749-26-025922.md) | [141](/filings/0001437749-26-025922.md) |
| Total liabilities | $m | [94.4](/filings/0001437749-23-029753.md) | [86.8](/filings/0001437749-24-002041.md) | [88.2](/filings/0001437749-25-017986.md) | [96.8](/filings/0001437749-24-024886.md) | [111](/filings/0001437749-24-032618.md) | [118](/filings/0001437749-25-002900.md) | [113](/filings/0001437749-26-018542.md) | [120](/filings/0001437749-25-023968.md) | [103](/filings/0001437749-25-033351.md) | [183](/filings/0001437749-26-002978.md) | [184](/filings/0001437749-26-025922.md) | [190](/filings/0001437749-26-025922.md) |
| Long-term debt | $m | [0.0](/filings/0001437749-23-029753.md) | [0.0](/filings/0001437749-24-002041.md) | [0.0](/filings/0001437749-24-018602.md) | not reported | not reported | not reported | [0.0](/filings/0001437749-26-002978.md) | not reported | not reported | [6.1](/filings/0001437749-26-002978.md) | not reported | not reported |
| Current portion of debt | $m | [0.1](/filings/0001437749-23-029753.md) | [0.0](/filings/0001437749-24-002041.md) | [0.0](/filings/0001437749-25-017986.md) | [0.0](/filings/0001437749-24-024886.md) | [0.0](/filings/0001437749-24-032618.md) | [0.0](/filings/0001437749-25-002900.md) | [0.0](/filings/0001437749-26-002978.md) | not reported | not reported | [1.6](/filings/0001437749-26-002978.md) | not reported | not reported |
| Shareholders' equity | $m | [76.9](/filings/0001437749-25-002900.md) | [79.5](/filings/0001437749-25-002900.md) | [145](/filings/0001437749-26-018542.md) | [143](/filings/0001437749-26-002978.md) | [187](/filings/0001437749-26-002978.md) | [193](/filings/0001437749-26-002978.md) | [197](/filings/0001437749-26-025922.md) | [333](/filings/0001437749-26-025922.md) | [342](/filings/0001437749-26-002978.md) | [537](/filings/0001437749-26-002978.md) | [555](/filings/0001437749-26-025922.md) | [572](/filings/0001437749-26-025922.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | Q4 FY2023 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q3 FY2024 (2024-12-31) | Q4 FY2024 (2025-03-31) | Q1 FY2025 (2025-06-30) | Q2 FY2025 (2025-09-30) | Q3 FY2025 (2025-12-31) | Q4 FY2025 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.9 d](/filings/0001437749-24-032618.md) | [1.3 d](/filings/0001437749-25-002900.md) | [2.2 d](/filings/0001437749-26-018542.md) | [3.4](/filings/0001437749-25-023968.md) | [12.7 d](/filings/0001437749-25-033351.md) | [5.9 d](/filings/0001437749-26-002978.md) | [6.3 d](/filings/0001437749-26-018542.md) | [4.1](/filings/0001437749-26-025922.md) | [6.5 d](/filings/0001437749-25-033351.md) | [3.2 d](/filings/0001437749-26-002978.md) | [9.3 d](/filings/0001437749-26-018542.md) | [16.0](/filings/0001437749-26-025922.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001437749-24-032618.md) | [0.2 d](/filings/0001437749-25-002900.md) | [0.3 d](/filings/0001437749-26-018542.md) | [0.3](/filings/0001437749-25-023968.md) | [0.6 d](/filings/0001437749-25-033351.md) | [0.5 d](/filings/0001437749-26-002978.md) | [1.0 d](/filings/0001437749-26-018542.md) | [0.8](/filings/0001437749-26-025922.md) | [1.4 d](/filings/0001437749-25-033351.md) | [0.9 d](/filings/0001437749-26-002978.md) | [1.8 d](/filings/0001437749-26-018542.md) | [10.4](/filings/0001437749-26-025922.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001437749-25-002900.md) | [0.0 d](/filings/0001437749-26-018542.md) | not reported | not reported | [0.0 d](/filings/0001437749-26-002978.md) | [0.0 d](/filings/0001437749-26-018542.md) | not reported | not reported | [0.0 d](/filings/0001437749-26-002978.md) | [0.0 d](/filings/0001437749-26-018542.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q4 FY2022 (2023-03-31) | Q1 FY2023 (2023-06-30) | Q2 FY2023 (2023-09-30) | Q3 FY2023 (2023-12-31) | Q4 FY2023 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q2 FY2024 (2024-09-30) | Q3 FY2024 (2024-12-31) | Q1 FY2025 (2025-06-30) | Q2 FY2025 (2025-09-30) | Q3 FY2025 (2025-12-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [27.8](/filings/0001437749-24-018602.md) | [28.3](/filings/0001437749-24-024886.md) | [28.8](/filings/0001437749-24-032618.md) | [29.1](/filings/0001437749-25-002900.md) | [29.8](/filings/0001437749-24-018602.md) | [0.0](/filings/0001437749-25-023968.md) | [0.0](/filings/0001437749-25-033351.md) | [38.5](/filings/0001437749-26-002978.md) | [39.7](/filings/0001437749-26-025922.md) | [0.0](/filings/0001437749-25-033351.md) | [44.9](/filings/0001437749-26-002978.md) | [47.1](/filings/0001437749-26-025922.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 48,442,143 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001437749-26-025922.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. No prices; not investment advice.